Webinar | Watchman | Left Atrial Appendage closure device
Tue, May 19
|Webinar
Coming soon | A one-time procedure that may reduce stroke risk for a lifetime in people with AFib not caused by a heart valve problem.
Time & Location
May 19, 2020, 5:00 PM PDT
Webinar
Guests
About the Event
In 30 minutes, learn about the Watchman procedure, an innovative one-time procedure that reduces the risk of stroke in your non-valvular atrial fibrillation (NVAF) patients and the long-term risk of bleeding that comes with a lifetime of warfarin use.
In patients with non-valvular atrial fibrillation (NVAF), more than 90% of stroke-causing clots that come from the left atrium form in the left atrial appendage (LAA). 3 WATCHMAN closes off the LAA, preventing blood clots from migrating out of it. The procedure is performed under general anesthesia in a catheterization laboratory using a standard percutaneous technique. This minimally invasive procedure usually lasts about an hour and patients typically stay in the hospital for a day. Following the procedure, patients typically take warfarin and aspirin for 45 days or until there is adequate seal. After discontinuing warfarin, patients take clopidogrel and an increased dose of aspirin, followed by ongoing aspirin therapy.
Register…